Valproic acid induces manifestations of simultaneous dopamine enhancement and reduction in schizophrenia (multiple letters)

Neuropsychopharmacology

Volumn 29, Issue 6, 2004, Pages 1217-1220

  Lopez, Lina M ^a   Wassef, Adel A ^a   Molloy, Melissa S ^a   Williams, Nina G ^a   Winterer, Georg ^b   Schmitt, Ulrich ^b   Schmidt, Lutz G ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZATROPINE; DOPAMINE; DOPAMINE 5 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GALACTORRHEA; HUMAN; LETTER; NECK PAIN; NIGRONEOSTRIATAL SYSTEM; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SLURRED SPEECH; SPASTICITY; TONGUE DISEASE;

EID: 2442642556     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300461     Document Type: Letter

References (0)